by Shivum Agarwal
Abstract
With the recent advent of the drug eluding stent as a possible alternative for coronary artery bypass graft (CABG) surgery, the economics of cardiac healthcare have shifted dramatically. Many doctors are now electing to send their patients to an invasive cardiologist for cardiac catheterization rather than for open heart surgery. However, the debate continues as to whether stenting is a viable alternative to open heart surgery. This study seeks to approach this problem with an economic analysis of the comparative cost‐effectiveness of the two procedures. Using a variety of statistical techniques including conventional mean differences tests and linear probability models, we test the relative effectiveness of the different treatment options.
Professor Lori Leachman, Faculty Advisor
JEL Codes: I1, I12
